Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-15 Purchase(A) |
2020-06-15 6:39 pm |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
100,000 | $1.289 | $128,900 | 178,750 (Direct) |
View |
| 2020-06-15 Purchase |
2020-06-15 6:01 pm |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
100,000 | $1.289 | $128,900 | 178,750 (Direct) |
View |
| 2020-06-15 Purchase |
2020-06-15 6:00 pm |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
7,547 | $1.3297 | $10,035 | 468,757 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-11 Tax Withholding |
2022-02-14 4:49 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
23,058 | $0.4014 | 1,763,570 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-14 4:49 pm |
N/A 2032-02-11 |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
1,170,000 | $0 | 1,763,570 (Direct) |
View |
| 2022-02-06 Tax Withholding |
2022-02-07 8:20 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer |
9,391 | $0.4312 | 662,611 (Direct) |
View |
| 2022-02-06 Tax Withholding |
2022-02-07 8:19 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer |
6,830 | $0.4312 | 204,322 (Direct) |
View |
| 2022-02-06 Tax Withholding |
2022-02-07 7:58 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer |
9,391 | $0.4312 | 258,515 (Direct) |
View |
| 2022-02-06 Tax Withholding |
2022-02-07 7:57 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
27,318 | $0.4312 | 616,628 (Direct) |
View |
| 2021-11-20 Option Award |
2021-11-23 5:37 pm |
N/A 2031-11-19 |
ACELRX PHARMACEUTICALS INC | ACRX | Broadfoot Jill Marie Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:33 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | WAN MARK A Director |
30,000 | $0 | 41,250 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:32 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
30,000 | $0 | 216,250 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:31 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | Rosen Howard B Director |
30,000 | $0 | 98,750 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:28 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | Afable Richard Director |
30,000 | $0 | 42,250 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:27 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | Bozilenko Marina Director |
30,000 | $0 | 45,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:25 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | HOFFMAN STEPHEN J Director |
30,000 | $0 | 41,250 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:23 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | EDWARDS MARK G Director |
30,000 | $0 | 281,250 (Direct) |
View |
| 2021-03-30 Option Award |
2021-03-31 5:22 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Bozilenko Marina Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:34 pm |
N/A 2031-03-03 |
ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer |
206,250 | $0 | 872,871 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:32 pm |
N/A 2031-03-03 |
ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer |
150,000 | $0 | 354,757 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:30 pm |
N/A 2031-03-03 |
ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer |
206,250 | $0 | 466,847 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:28 pm |
N/A 2031-03-03 |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
1,200,000 | $0 | 1,636,980 (Direct) |
View |
| 2021-02-11 Tax Withholding |
2021-02-12 5:55 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer |
9,024 | $2.63 | 183,299 (Direct) |
View |
| 2021-02-11 Tax Withholding |
2021-02-12 5:53 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer |
6,775 | $2.63 | 144,757 (Direct) |
View |
| 2021-02-11 Tax Withholding |
2021-02-12 5:51 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer |
8,915 | $2.63 | 593,098 (Direct) |
View |
| 2021-02-11 Tax Withholding |
2021-02-12 5:50 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
23,052 | $2.63 | 427,887 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-02-09 4:33 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer |
9,414 | $2.59 | 192,323 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-02-09 4:31 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer |
6,846 | $2.59 | 151,532 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-02-09 4:30 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer |
9,414 | $2.59 | 602,013 (Direct) |
View |
| 2021-02-06 Tax Withholding |
2021-02-09 4:29 pm |
N/A N/A |
ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer |
25,059 | $2.59 | 450,939 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:17 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | Afable Richard Director |
22,500 | $0 | 27,250 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:16 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | EDWARDS MARK G Director |
22,500 | $0 | 266,250 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:15 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | HOFFMAN STEPHEN J Director |
22,500 | $0 | 26,250 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:14 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | Rosen Howard B Director |
22,500 | $0 | 83,750 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:13 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
22,500 | $0 | 201,250 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:12 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | WAN MARK A Director |
22,500 | $0 | 26,250 (Direct) |
View |